<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://www.healthnewspapers.com/womens-health/weight-loss-ovulation-pcos-bambini</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-03</news:publication_date>
      <news:title>In PCOS and obesity, more weight loss meant more ovulation — with no upper limit found</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/womens-health/prevent-pe-scheduled-birth-preeclampsia</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-03</news:publication_date>
      <news:title>A 36-week screen and planned early birth cut term pre-eclampsia in a UK trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/womens-health/icsi-versus-ivf-no-severe-male-factor</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-03</news:publication_date>
      <news:title>ICSI is used well beyond male infertility. A review finds no live-birth benefit</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/womens-health/hpv-vaccination-cervical-cancer-mortality-england</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-03</news:publication_date>
      <news:title>England&apos;s HPV programme now shows up in the hardest number: cervical cancer deaths</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/tech-medicine/ai-colonoscopy-lynch-syndrome-cadly2</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-03</news:publication_date>
      <news:title>AI did not raise adenoma detection in Lynch syndrome colonoscopy, a trial found</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/science/ukall14-nelarabine-adult-t-cell-all</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-03</news:publication_date>
      <news:title>Adding nelarabine to adult T-ALL therapy did not improve survival in UKALL14</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/science/two-gene-urine-methylation-prostate-cancer-assay</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-03</news:publication_date>
      <news:title>A two-gene urine test aims to cut needless prostate biopsies in the PSA grey zone</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/science/pluss-budesonide-surfactant-preterm-bpd</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-03</news:publication_date>
      <news:title>Adding budesonide to surfactant did not improve lung outcomes in extremely preterm babies</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/science/onabotulinumtoxina-foot-dystonia-parkinsons-pain</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-03</news:publication_date>
      <news:title>Botulinum toxin eased painful foot dystonia in Parkinson&apos;s — in a 33-patient trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/science/impassion050-atezolizumab-her2-early-breast</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-03</news:publication_date>
      <news:title>Atezolizumab added nothing to HER2-positive breast cancer therapy in IMpassion050</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/science/human-metapneumovirus-rsv-hospital-burden-scotland</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-03</news:publication_date>
      <news:title>A neglected respiratory virus sends adults to hospital about as sick as RSV</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/science/guardian-newborn-genome-sequencing-screening</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-03</news:publication_date>
      <news:title>A New York study added genome sequencing to newborn screening. 3.7% screened positive</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/science/cll6-residuum-lenalidomide-maintenance-cll</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-03</news:publication_date>
      <news:title>Lenalidomide maintenance delayed CLL progression but not death in CLL6</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/science/baloxavir-influenza-transmission-centerstone</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-03</news:publication_date>
      <news:title>Baloxavir cut influenza transmission in a trial, but not symptomatic cases</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/science/asac-aspirin-colorectal-liver-metastases</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-03</news:publication_date>
      <news:title>Aspirin did not prevent recurrence after colorectal liver metastasis surgery</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/policy/ipf-pps-fy2027-psychiatric-payment-update</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-03</news:publication_date>
      <news:title>Medicare sets a 2.3% payment rise for inpatient psychiatric care in 2027</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/policy/fda-vitamin-d2-bakers-yeast-food-additive</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-03</news:publication_date>
      <news:title>FDA clears inactive baker&apos;s yeast as a vitamin D2 source in four food groups</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/policy/fda-denies-510k-exemption-radiology-cad-software</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-03</news:publication_date>
      <news:title>FDA keeps premarket review for radiology AI detection and triage software</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/policy/cms-globe-part-b-drug-pricing-model</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-03</news:publication_date>
      <news:title>Medicare&apos;s new GLOBE model ties some Part B drug rebates to overseas prices</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/mind/buprenorphine-after-ketamine-suicidal-ideation-trial</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-03</news:publication_date>
      <news:title>A low-dose opioid was tested to make ketamine&apos;s anti-suicidal effect last longer</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/global-health/shigella-efgh-surveillance-amr-seven-countries</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-03</news:publication_date>
      <news:title>Shigella found in one in five young children&apos;s diarrhoea, with resistance climbing</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/global-health/second-hand-smoke-global-burden-gbd-2023</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-03</news:publication_date>
      <news:title>2.71 billion people breathed second-hand smoke in 2023, first global GBD estimate</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/global-health/pertussis-resurgence-japan-2025</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-03</news:publication_date>
      <news:title>Whooping cough surged in Japan in 2025 as it ebbed elsewhere in the Pacific</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/global-health/norway-alcohol-advertising-ban-50-years</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-03</news:publication_date>
      <news:title>Norway&apos;s total ban on alcohol advertising turns 50, and a review asks what held it up</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/global-health/heart-failure-global-burden-gbd-2023</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-03</news:publication_date>
      <news:title>56 million people were living with heart failure in 2023, global GBD analysis finds</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/global-health/health-workforce-sex-composition-uhc-gaps-gbd-2023</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-03</news:publication_date>
      <news:title>The world had 122 million health workers in 2023, and women drove most of the growth</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/body/sepiapterin-sephience-phenylketonuria</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-03</news:publication_date>
      <news:title>Sepiapterin, a new oral drug for phenylketonuria, cut blood phenylalanine by 63%</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/body/semaglutide-stride-peripheral-artery-walking</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-03</news:publication_date>
      <news:title>Semaglutide improved walking distance in peripheral artery disease</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/body/pfa-posterior-wall-isolation-persistent-af-pifpaf</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-03</news:publication_date>
      <news:title>Adding posterior-wall ablation to pulsed-field therapy missed its mark in persistent AF</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/body/muvalaplin-kraken-oral-lipoprotein-a-phase-2</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-03</news:publication_date>
      <news:title>An oral pill cut lipoprotein(a) up to 85.8% — with no evidence yet on events</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/body/mepolizumab-copd-eosinophilic-matinee</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-03</news:publication_date>
      <news:title>Mepolizumab modestly cut COPD flare-ups, with no gain in quality of life</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/body/lutikizumab-hidradenitis-suppurativa-phase-2</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-03</news:publication_date>
      <news:title>An IL-1 blocker helped hard-to-treat hidradenitis — but its lowest dose lost to placebo</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/body/lerodalcibep-liberate-hr-pcsk9-ldl</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-03</news:publication_date>
      <news:title>A monthly PCSK9 shot cut LDL about 56% on top of statins</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/body/givinostat-duvyzat-duchenne-epidys</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-03</news:publication_date>
      <news:title>Givinostat slowed, but did not stop, motor decline in Duchenne muscular dystrophy</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/body/functional-alignment-robotic-knee-replacement-rct</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-03</news:publication_date>
      <news:title>Robot-set functional alignment edged mechanical alignment in a knee-replacement trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/body/empagliflozin-empact-mi-heart-failure-death</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-03</news:publication_date>
      <news:title>Empagliflozin after a heart attack did not cut heart failure or death</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/body/amplified-abatacept-adalimumab-early-rheumatoid-arthritis</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-03</news:publication_date>
      <news:title>A trial picked the patients most likely to favour abatacept. They didn&apos;t.</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/global-health/etvax-etec-vaccine-gambian-children-phase-2b</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-02</news:publication_date>
      <news:title>ETEC vaccine misses primary goal in Gambian infants but cuts severe diarrhoea</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/global-health/beat-tuberculosis-six-month-rifampicin-resistant-south-africa</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-02</news:publication_date>
      <news:title>Six-month regimen matches nine months for drug-resistant TB in South African trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/body/vitruvias-thyroid-tablets-superpotent-recall</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-02</news:publication_date>
      <news:title>Vitruvias recalls a lot of thyroid tablets found to be superpotent, in a Class I action</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/body/rezafungin-rezzayo-paediatric-candidaemia-approval</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-02</news:publication_date>
      <news:title>FDA extends the antifungal rezafungin to children 12 and older, without a paediatric trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/body/omnipod-5-pod-cannula-insulin-recall</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-02</news:publication_date>
      <news:title>Insulet recalls millions of Omnipod 5 pods over cannula defects that cut insulin</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/global-health/south-africa-viral-suppression-durability-nhls-cohort</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-01</news:publication_date>
      <news:title>South Africa&apos;s HIV data back U=U: 96% stayed below transmission risk at 12 months</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.healthnewspapers.com/body/tislelizumab-zanidatamab-her2-gastric-approval</loc>
    <news:news>
      <news:publication>
        <news:name>Health Newspapers</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-01</news:publication_date>
      <news:title>FDA clears tislelizumab plus zanidatamab for HER2-positive gastric cancer</news:title>
    </news:news>
  </url>
</urlset>